| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Andrew Shaker, Rowena Jone. Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. Therapeutic advances in psychopharmacology. vol 8. issue 1. 2020-09-30. PMID:29344339. |
a case note review was therefore conducted to ascertain medium-term prognoses in patients with treatment-resistant schizophrenia under an early intervention service (eis) following clozapine discontinuation. |
2020-09-30 |
2023-08-13 |
Not clear |
| Afaque H Khan, Samina Zaid. Clozapine: Improvement of Negative Symptoms of Schizophrenia. Cureus. vol 9. issue 12. 2020-09-30. PMID:29492362. |
clozapine: improvement of negative symptoms of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Afaque H Khan, Samina Zaid. Clozapine: Improvement of Negative Symptoms of Schizophrenia. Cureus. vol 9. issue 12. 2020-09-30. PMID:29492362. |
clozapine has been established to be more beneficial than conventional antipsychotics in patients with treatment-resistant schizophrenia and apparently more useful, based on existing evidence, in managing the negative symptoms of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Marta Szlachta, Maciej Kuśmider, Paulina Pabian, Joanna Solich, Magdalena Kolasa, Dariusz Żurawek, Marta Dziedzicka-Wasylewska, Agata Faron-Góreck. Repeated Clozapine Increases the Level of Serotonin 5-HT Frontiers in molecular neuroscience. vol 11. 2020-09-30. PMID:29497362. |
repeated clozapine increases the level of serotonin 5-ht g-protein-coupled receptor (gpcr) heterodimers are new targets for the treatment of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti, Massimo Di Giannantoni. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic advances in drug safety. vol 9. issue 5. 2020-09-30. PMID:29796248. |
safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. |
2020-09-30 |
2023-08-13 |
Not clear |
| Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti, Massimo Di Giannantoni. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic advances in drug safety. vol 9. issue 5. 2020-09-30. PMID:29796248. |
clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti, Massimo Di Giannantoni. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic advances in drug safety. vol 9. issue 5. 2020-09-30. PMID:29796248. |
as poor treatment adherence in patients with resistant schizophrenia may increase the risk of a psychotic relapse, which may further lead to impaired social and cognitive functioning, psychiatric hospitalizations and increased treatment costs, clozapine adverse effects are a common reason for discontinuing this medication. |
2020-09-30 |
2023-08-13 |
Not clear |
| Jung Hyun Kim, Tak Youn, Jun Gwon Choi, Seong Hoon Jeong, Hee Yeon Jung, Yong Sik Kim, In Won Chun. Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia. Psychiatry investigation. vol 15. issue 8. 2020-09-30. PMID:30086612. |
combination of electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Allison Karst, Jonathan Liste. Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion. The mental health clinician. vol 8. issue 5. 2020-09-30. PMID:30206510. |
clozapine remains the definitive gold standard for treatment-resistant schizophrenia despite limitations in use because of hematological abnormalities. |
2020-09-30 |
2023-08-13 |
Not clear |
| Alex Till, James Selwood, Edward Silv. The assertive approach to clozapine: nasogastric administration. BJPsych bulletin. vol 43. issue 1. 2020-09-30. PMID:30223913. |
results: five of the most extremely ill patients with treatment-resistant schizophrenia were established and/or maintained on clozapine, resulting in improvements to their mental state; incidents were reduced, segregation was terminated and progression to less restrictive environments was achieved.clinical implicationsdespite being underutilised and rarely enforced, in extreme circumstances, an assertive approach to clozapine can be justified. |
2020-09-30 |
2023-08-13 |
Not clear |
| Alex Till, James Selwood, Edward Silv. The assertive approach to clozapine: nasogastric administration. BJPsych bulletin. vol 43. issue 1. 2020-09-30. PMID:30223913. |
nasogastric clozapine can be safely delivered and the approach itself, rather than actual nasogastric administration, may be enough to help establish and maintain patients with treatment-resistant schizophrenia on the most effective treatment.declaration of intereste.s. |
2020-09-30 |
2023-08-13 |
Not clear |
| Bryan K Sackey, Troy A Moore, Nicole L Cupples, Cynthia A Gutierre. Clozapine-induced myocarditis: Two case reports and review of clinical presentation and recognition. The mental health clinician. vol 8. issue 6. 2020-09-30. PMID:30397572. |
the second patient was a 45-year-old black male who was initiated on clozapine for treatment-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid, Alix Dufresn. Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case reports in medicine. vol 2019. 2020-09-30. PMID:31049067. |
clozapine is an atypical antipsychotic agent indicated in the treatment of medication-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Mazin Khalid, Oluwole Jegede, Vijay Gayam, Ying Chi Yang, Binav Shrestha, Amrendra Mandal, Osama Mukhtar, Pavani Garlapati, Mowyad Khalid, Alix Dufresn. Clozapine-Induced Cardiotoxicity Presenting as Sepsis: A Case Report and Literature Review. Case reports in medicine. vol 2019. 2020-09-30. PMID:31049067. |
we present a 21-year-old patient who was started on clozapine for management of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Yuji Otsuka, Keita Idemoto, Yutaka Hosoda, Yukitsugu Imamura, Tsutomu Aok. Clozapine-induced myocarditis: Follow-up for 3.5 years after successful retrial. Journal of general and family medicine. vol 20. issue 3. 2020-09-30. PMID:31065477. |
it may be possible to take clozapine for a long time even after clozapine-induced myocarditis, and thus improve the life expectancy of schizophrenia patients. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pradeep Kumar, Dheerendra Kumar Mishra, Nimisha Mishra, Sunil Ahuja, Gyanendra Raghuvanshi, Vijay Niranja. Acute onset clozapine-induced hyperglycaemia: A case report. General psychiatry. vol 32. issue 2. 2020-09-30. PMID:31179433. |
clozapine is reserved especially for resistant schizophrenia due to its side effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pradeep Kumar, Dheerendra Kumar Mishra, Nimisha Mishra, Sunil Ahuja, Gyanendra Raghuvanshi, Vijay Niranja. Acute onset clozapine-induced hyperglycaemia: A case report. General psychiatry. vol 32. issue 2. 2020-09-30. PMID:31179433. |
in this case, a patient with resistant schizophrenia was presented with acute-onset hyperglycaemia and delirium with the use of clozapine within a week. |
2020-09-30 |
2023-08-13 |
Not clear |
| Masashi Ito, Yasuto Kunii, Sho Horikoshi, Itaru Miura, Shuntaro Itagaki, Tetsuya Shiga, Hirooki Yab. Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report. International medical case reports journal. vol 12. 2020-09-30. PMID:31297000. |
young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report. |
2020-09-30 |
2023-08-13 |
Not clear |
| Asiel Yair Adan Sanchez, Jessica J Foster, Carla M Plymen, Sukhi Shergil. Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report - ADDENDUM. BJPsych open. vol 5. issue 4. 2020-09-30. PMID:31530298. |
clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report - addendum. |
2020-09-30 |
2023-08-13 |
Not clear |
| Gabriela D William. Cross-reaction of angioedema with clozapine, olanzapine, and quetiapine: A case report. The mental health clinician. vol 9. issue 5. 2020-09-30. PMID:31534873. |
a 67-year-old african american male with a past medical history significant for hypertension, coronary artery disease requiring stent placement, mitral insufficiency, hyperlipidemia, tobacco use disorder, and schizophrenia presented with altered mental status and disorientation in the setting of clozapine nonadherence, which prompted acute hospitalization for clozapine reinitiation. |
2020-09-30 |
2023-08-13 |
Not clear |